Retrovirus vectors [direct orientation (DO) vectors] that permit the simultaneous expression of an inserted protein-coding sequence and a dominant-acting selectable marker have been constructed. In these vectors, an internal simian virus 40 or human metallothionein promoter sequence serves to drive the expression of the bacterial neomycin phosphotransferase or guanine-xanthine phosphoribosyltransferase genes, whereas the viral long terminal repeat sequences are utilized to promote expression of inserted sequences. In some of the vectors, the viral 5' splice site, normally used in the biogenesis of the subgenomic env-encoding mRNA, has been eliminated. These vectors yield high transient and stable titers of virus after transfection of viral packaging cell lines, show little or no depression of virus titer with a variety of inserts, and faithfully transmit recombinant proviral sequences to recipient cells. To characterize the expression potential of these vectors, a variety of inserts encoding the a and (3 subunits of the human major histocompatibility complex class HI antigen HLA-DR have been introduced into these vectors. NIH 3T3 cells infected by viruses containing HLA-DR a or (3 cDNAs express these proteins as shown by immunoprecipitation of metabolically labeled extracts. In addition, through the sequential infection of cells with retrovirus constructions expressing two different selectable markers, both subunits of the class II antigen have been introduced into NIH 3T3 cells. Such infected cells express HLA-DR molecules at the cell surface.
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HLA-DR antigens and their murine homologs, the Ia antigens, are membrane glycoproteins that mediate recognition events by regulatory T cells resulting in the capacity to generate an immune response (1) . Class II molecules are recognized together with antigen on the surface of antigenpresenting cells by major histocompatibility complex (MHC)-restricted, antigen-specific T cells. The physiological sites of class II antigen expression include macrophages, dendritic cells, B cells, and activated human T cells; many cell types express class II antigens after treatment with y-interferon. Class II antigens consist of two chains containing four external domains, two of which are homologous to immunoglobulin domains (2, 3) . Polymorphism in the ,B chain of class II antigens (and the a chain of some isotypes) results in heritable differences in immune responsiveness.
To characterize further the biochemistry of antigen recognition by T cells, DNA-mediated gene transfer has been used to introduce and express class II antigen genes in B-cell tumors, macrophage lines, and fibroblasts (reviewed in ref. 4) . These studies have shown that newly introduced class II antigens function as recognition elements for alloreactive and antigen-specific, MHC-restricted T-cell hybridomas and clones and that fibroblasts are capable of processing antigen into an immunogenic form. However, differences in the capacity of fibroblasts to present various antigens have been observed (5) . Site-directed mutagenesis and exon shuffling experiments of class II genes have begun to define the regions and residues involved in T-cell recognition (6) (7) (8) .
To extend these studies, we have approached the problem of introducing class II antigens into various cells through the use of transmissible retrovirus vectors (9) (10) (11) . First, such vectors offer a highly efficient means of introducing genes into a wide variety of cells in vitro and in vivo. This feature of retrovirus vectors is particularly relevant for the study of class II MHC antigens, since dissection of the function of these molecules may require the introduction of these genes into a variety of specialized immunocompetent cells as well as in cells that do not normally express class II antigens. Another potentially useful feature of the retrovirus vector system is the ability to generate, segregate, and rescue recombinant viral genomes harboring well-defined or randomly generated mutations. In this paper, we describe the construction of a number of retrovirus vectors [direct orientation (DO) vectors] that express a selectable marker gene through the use of an internal promoter and an inserted sequence under the control of the viral long terminal repeat (LTR). Retroviruses encoding the a and , chains of HLA-DR have been used to express the HLA-DR heterodimer at the surface of infected NIH 3T3 cells.
MATERIALS AND METHODS
Transfection and Infection. Procedures for the growth of cells, transfection of cells, harvest of virus, and infection of cells were performed as described (12, 13) . For G418 selection, cells were selected in 1 mg of G418 (Geneticin, GIBCO) per ml. gpt selections were performed as described (14) with the addition of 50 AM ZnCl2.
Vector Constructions. Details of constructs are given in the legend to Fig. 1 . The murine leukemia virus (MLV) splice donor was mutated by using the following oligonucleotide: 5' CCAGCTTATCTCCCGGT 3'. The mutagenesis protocol consisted of hybridizing the oligonucleotide to plasmids containing a single-stranded gap at the location of the oligonucleotide (15) . These plasmids were formed from the following fragments: a DO1 plasmid ( (12, 13) . cDNA for the a chain of HLA-DR was inserted into the "gag" position of MSV-gpt and transfected into f-2, a helper-free retrovirus packaging cell line (12 (18), encompassing the simian virus 40 (SV40) promoter and neo sequences, and a 7.2-kb BamHI-Cla I fragment of pZipSV(X) (13) . The Acc I site in the pSV2neo fragment was converted to a BamHI site and the Sma I site was converted to a Cla I site. (b) DOMTIIgpt. Clockwise from the BamHI site is an 830-base-pair (bp) HindllI-Nco I fragment containing the human metallothionein promoter (MTIH) (19) , a 700-bp Xho I-Dra I fragment of MSV-gpt (12) containing the gpt gene, and the 7.2-kb BamHI-Cla I fragment of pZipSV(X). The HindIll at the 5' end of the MTH sequence was converted to aBamHI site and the Nco I site at the 3' end was converted to an Xho I site. The Dra I site at the 3' end of the gpt fragment was converted to a Cla I site. (c) DOL and DOL-. Clockwise to the BamHI-Sma I-Sal I polylinker is a 1.6-kb Pvu Hl-Sma I fragment from pSV2neo; a 1.05-kb EcoRI-Cla I fragment from pZipSV(X) that contains the pBR322 origin of replication and a fragment of MLV [nucleotide (nt) 7195-7674]; a 1.5-kb Cla I-Pst I fragment from the MOV9-2 provirus (20) containing the 3' LTR sequences and flanking mouse DNA sequences; a 3.8-kb HincJI-BamHI fragment of the polyoma genome containing the origin of replication and the early region (9) ; a 1.1-kb Pst I-Pst I fragment of MOV9-2 containing mouse flanking DNA sequences, the 5' viral LTR, and MLV sequences extending from the 5' LTR up to nt 563; and a 50-bp Pst I-Dde I fragment (MLV nt 563-613). The Pvu II site of the neo fragment was converted to a Sal I site and the Sma I site was converted to an EcoRI site. The Pst I site of the 3' LTR-containing fragment was converted to a Bgl II site. The HincII site of the polyoma fragment was converted to a BamHI site. The Pst I site at the 5' end of the 5' LTR-containing fragment was converted to a Bgl II site. The Dde I site at MLV nt 613 was converted to a BamHI site. Mutation of the 5' viral splice donor (denoted by the symbol X located near the 5' LTR) involved the introduction of the point mutation into DO1 and subsequent transfer to DOL (creating DOL-). The region between the Kpn I site at nt 32 and the Bal I site at nt 212 was replaced with a Kpn I-Alu I fragment (encompassing MLV nt 32-209) containing the mutated viral splice donor. cDNA inserts: For DRa, BamHI linkers were attached to an 1100-bp Pst I fragment from pDRal (21) . In DOL-cDRa, a portion of the 5' end ofthe DRa cDNA extending from the BamHI to the Bal I site was replaced by a 60-bp fragment from the DRa genomic clone extending from the Sst I site (which was converted to a BamHI site) to the Bal I site to remove the GC tails from the 5' end of the DRa cDNA. ) . Accordingly, viral sequences containing the splice donor were mutated by site-directed mutagenesis (GT to AT) and transferred to DOL. The resulting vector DOL-(or pLJ, constructed by J. Schwarzbauer, Massachusetts Institute of Technology) harbors the point mutation as well as a 4-bp deletion (nt 209-212). In the DO1 vector, the BamHI site used for the insertion of cDNA sequences into the vector was introduced at the MLV Pst I site at nt 563. In the DOL and DOLvectors, the BamHI-Sma I-Sal I polylinker was introduced at nt 613 to retain more ofthe normal viral sequences adjacent to the initiation codon for gag translation (nt 621).
To assess the transmission properties of these vectors, several constructs (with and without DRa and DRJ3 cDNA sequences) were transfected into 4-2 cells. Virus was rescued from the culture supernatant after 14-18 hr and titered on NIH 3T3 cells for G418 resistance. The DO1 vector yielded G418-resistant titers comparable to pZipSV(X), a splicing vector (Table 1 (25) (Fig. 2) . Extracts from each of three infected clones and a population of clones showed significant levels of DRa protein (Fig. 2, lanes c-f) (Fig. 3) . At short exposure times (Fig. 3 Upper) a DO-MTIIgpt construct containing the DRa cDNA (DO' MTIIgpt'cDRa) and the infected cells were selected for resistance to mycophenolic acid. Labeled extracts prepared from a pool of such doubly infected, G418-and mycophenolic acid-resistant cells (line 220-167) were then analyzed for the expression of the DRa chain and DR heterodimer (Fig. 4) . Immunoprecipitation of the extracts with HC2.1, a monoclonal antibody specific for DRa, indicated that significant levels of DRa are produced (Fig. 4, lane b) . In this case the extract was boiled in 1% NaDodSO4, which separates DRa and DR,8 chains. Similarly, immunoprecipitation of the extracts (without boiling in NaDodSO4) with L243, a monoclonal antibody specific for the HLA-DR complex, revealed expression of a linked DRa and DR/3 heterodimer.
To establish whether these cells express the HLA-DR heterodimer at the cell surface, the cells were analyzed by flow cytometry (Fig. 5) . NIH 3T3 cells infected with DO1 cDRa virus (75Ip) (trace a), doubly infected cells (220-167) (trace b), and an Epstein-Barr virus-transformed B-lymphoblastoid cell line (Priess) (trace c) were stained with L243 and fluorescein isothiocyanate-labeled sheep antimouse F(ab')2. All of the cells from 220-167, the doubly infected pool, expressed HLA-DR molecules at the cell surface with a broad distribution of expression. The expression level of the heterodimer in these NIH 3T3 cells was lower by several factors than that in the B-cell line Priess.
DISCUSSION
Retrovirus-mediated gene transfer is a potentially powerful means for transferring genes into animal cells, in vivo and in vitro, owing to the wide host range of the viruses and their efficient mechanism for integration of the viral genome into host cell DNA. Accordingly, there has been increasing interest in the development of general strategies for utilizing these viruses to obtain the transfer and efficient expression of DNA sequences (9-11). Previously, we described the construction and properties of a series of vectors that employ the normal viral transcription unit for the coexpression of inserted sequences and selectable markers (12, 13) . Though we and others have successfully used these types of vectors to transfer and express a number of sequences (for example, refs. 22 and 30) , in a minority of cases, difficulties have been encountered with the transfer of particular sequences (unpublished data; ref. 31). In the specific case referred to herein, the insertion of a number of HLA-DR cDNA sequences, in either orientation, led to a dramatic reduction in the titer of recombinant viruses (as compared to vector alone). Furthermore, the rare selected transformants were shown to harbor rearranged proviral sequences lacking all or a portion of the inserted sequences. Because the inserted sequences were suspected to have interfered with the generation of subgenomic RNA encoding the selectable marker, vectors in which marker expression should be independent of viral transcription were designed. These vectors (DO) contain internal promoters, SV40 or MTII, which drive the expression of a selectable marker in the same orientation as the viral LTR (Fig. 1) . The data presented here indicate that these vectors can be successfully used to transfer the HLA-DR a-and a-chain cDNA sequences to cells and promote the expression of HLA-DR protein. Similar success has been obtained with a variety of other inserts, including the HLA class I heavy chain (32), the class II-associated invariant chain (32) , the murine T-cell antigen receptor a and f8 chains (A.J.K., unpublished data), c-src (33) , and the polymeric immunoglobulin receptor (34) .
The mechanism leading to the difficulty with the splicing vectors remains unclear. One possibility is that the insertion of specific sequences leads to the generation of aberrantly spliced subgenomic transcripts, thereby dramatically reducing the amount of the correctly spliced marker RNA. Alternatively, the inserted sequences may suppress splicing altogether or reduce the amount of full-length genomic RNA by other means. The present results suggest that the principal important feature of the DO vectors is the independent expression of selectable marker sequences. Derivatives in which the viral splice donor sequences have been mutated were also constructed, so as to prevent the generation of aberrantly spliced transcripts. In a small number of cases, retention of the donor sequences has led to the generation of aberrantly spliced RNAs, which utilize the normal viral donor sequence (J. Schwarzbauer, R. Hynes, and R.C.M. and 0. Danos, M. Yaniv, and R.C.M., unpublished data).
This suggests that DOL-should be employed when utilizing the vector to recover spliced versions of inserted genomic DNA sequences (13, 24, 35) .
Though others have described a number of vectors similar to those described here (36) (37) (38) (39) 
